All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drselenajenner on Instagram · 41s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @drselenajenner's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00So, why didn't it work again?
  2. 0:03Why am I so slow?
  3. 0:05Keep up, man!
  4. 0:06What's happening to me? You're falling apart!
  5. 0:11They just don't have enough strength to reach the goal.
  6. 0:16So they try but can't? You're not broken, but things inside you aren't working at full strength.
  7. 0:21So what does that mean? It means they're slower than they should be.
  8. 0:24Some don't move well, some get tired too fast, and some just don't make it far enough.
  9. 0:29Is that why nothing happens?
  10. 0:31Yes, they try, but the distance is too much for them.
  11. 0:34This is what happens inside our body.
  12. 0:36And this is just one of the examples which we regularly analyze on the channel.

@drselenajenner's pregnancy loss claims need context

Dr. Selena Jenner

Instagram creator

130.8K viewsView on Instagram

Quick answer

The video describes reduced sperm motility using lay metaphors but does not address the hormonal mechanisms most relevant to its TRT-focused audience, specifically that exogenous testosterone suppresses FSH and LH, which impairs spermatogenesis directly. The caption's claim about pre-implantation loss rates references a real body of literature but strips it of the chromosomal context that explains why most of those losses are not clinically actionable. Viewers seeking fertility guidance after TRT exposure need hormonal evaluation, not general sperm quality framing.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @drselenajenner's pregnancy loss claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@drselenajenner's pregnancy loss claims need context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@drselenajenner's pregnancy loss claims need context" from Dr. Selena Jenner. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video describes reduced sperm motility using lay metaphors but does not address the hormonal mechanisms most relevant to its TRT-focused audience, specifically that exogenous testosterone suppresses FSH and LH, which impairs spermatogenesis directly.

The reason this review is not generic is the source wording and the canonical claim label "trt ever wonder why perfectly timed cycles still don t lead to." In this clip, the useful excerpt is: "So, why didn't it work again?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Exogenous testosterone suppresses FSH and LH, which can significantly reduce or eliminate sperm production.
People who land here are usually comparing the Testosterone claim with FertilityJourney, ConceptionTips, and WomensHealth.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video describes reduced sperm motility using lay metaphors but does not address the hormonal mechanisms most relevant to its TRT-focused audience, specifically that exogenous testosterone suppresses FSH and LH, which impairs spermatogenesis directly.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video describes reduced sperm motility using lay metaphors but does not address the hormonal mechanisms most relevant to its TRT-focused audience, specifically that exogenous testosterone suppresses FSH and LH, which impairs spermatogenesis directly. The caption's claim about pre-implantation loss rates references a real body of literature but strips it of the chromosomal context that explains why most of those losses are not clinically actionable. Viewers seeking fertility guidance after TRT exposure need hormonal evaluation, not general sperm quality framing.
  • WHO 2021 reference values define normal progressive sperm motility at 30% or above. Below this threshold warrants clinical workup, not just lifestyle adjustment.
  • Exogenous testosterone suppresses FSH and LH, which can significantly reduce or eliminate sperm production. Men on TRT who want to conceive should discuss this with a reproductive specialist before assuming motility is their primary issue.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • WHO 2021 reference values define normal progressive sperm motility at 30% or above. Below this threshold warrants clinical workup, not just lifestyle adjustment.
  • Exogenous testosterone suppresses FSH and LH, which can significantly reduce or eliminate sperm production. Men on TRT who want to conceive should discuss this with a reproductive specialist before assuming motility is their primary issue.
  • Wilcox et al. (1988, NEJM) estimated that a substantial proportion of fertilized eggs are lost before or shortly after implantation, but most of these losses involve chromosomally abnormal embryos and are not a sign of treatable infertility.
  • Male factor, female factor, and combined or unexplained etiologies each account for roughly one-third of infertility cases per ASRM. Poor sperm motility is one variable among many.
  • Reduced motility (asthenozoospermia), low count (oligozoospermia), and poor morphology (teratozoospermia) are distinct findings on semen analysis. The video treats them as interchangeable, which they are not clinically.
  • A semen analysis is the first-line diagnostic test for male factor infertility. It should be interpreted alongside hormonal panels including FSH, LH, and total testosterone, especially in men with any history of exogenous hormone use.
  • Subclinical pregnancy loss described in the caption is a real phenomenon, but recurrent pregnancy loss (three or more consecutive losses) is a separate clinical diagnosis requiring dedicated evaluation beyond general fertility content.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drselenajenner actually say?

The video uses an extended metaphor framing sperm as exhausted runners who "try but can't" reach the finish line. The creator says they're "slower than they should be," that "some don't move well, some get tired too fast, and some just don't make it far enough." The caption separately claims that "up to 50% of all fertilized eggs never actually make it to implantation." These are two distinct claims bundled into one video, and it's worth separating them before grading either one.

The transcript itself is almost entirely metaphorical. There's no clinical terminology used, no specific diagnosis mentioned, and no distinction made between low motility, low count, or poor morphology. The video gestures at male factor infertility without naming it. That vagueness matters when you're trying to figure out what someone should actually do about it.

Does the science back this up?

On sperm motility specifically: yes, the basic biology is accurate. Sperm that can't swim effectively are less likely to fertilize an egg, and poor motility is one of the most common findings in male infertility workups. What the video skips is that motility is just one variable in a semen analysis, and it rarely tells the whole story on its own.

The implantation figure in the caption is where things get more complicated. The widely cited statistic that roughly 30-50% of fertilized eggs fail to implant comes from older research including Wilcox et al. (1988, New England Journal of Medicine), which followed women through early biochemical pregnancies. That study found that 22% of pregnancies were lost after implantation, with a larger proportion likely lost before any clinical detection. More recent estimates from Macklon et al. (2002, Human Reproduction Update) suggest the figure may be even higher when you account for pre-implantation losses. So the 50% claim in the caption is in the right ballpark, though it gets presented without any of the methodological nuance those studies actually contain.

What did they get wrong (or right)?

Credit where it's due: the general point that sperm quality affects conception outcomes is correct, and framing this for a general audience in plain language isn't inherently dishonest. The idea that "they try but the distance is too much for them" is a reasonable lay description of what reduced progressive motility looks like functionally.

What's missing is more of a problem than what's wrong. The video implies that sperm motility alone explains failed conception, which is an oversimplification. Female factor infertility accounts for roughly 40% of cases, male factor for another 40%, and combined or unexplained factors for the rest, according to the American Society for Reproductive Medicine. A video categorized under TRT and hormone optimization that talks only about sperm performance without mentioning hormonal causes, specifically low testosterone's documented effect on spermatogenesis, is leaving out the most clinically relevant part for its likely audience. Low testosterone can suppress FSH and LH, which directly impairs sperm production. That connection goes unmentioned.

The caption's implantation statistic is real but presented without context. Most of those losses are chromosomally abnormal embryos, not a sign that something is systematically wrong with a couple's fertility.

What should you actually know?

If you're a man concerned about sperm quality, the starting point is a semen analysis, not a metaphor about tired runners. Standard WHO 2021 reference values define normal progressive motility at 30% or above. Below that threshold warrants follow-up, but the next step is figuring out why, not assuming the answer.

For men on TRT specifically: exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis and can significantly reduce or eliminate sperm production. This is one of the most well-documented and clinically consequential facts about TRT, documented in studies including Grimes et al. (2012, Journal of Clinical Endocrinology and Metabolism). If you're on testosterone and trying to conceive, this video's framing of sperm as simply "tired" is not just incomplete, it's potentially misleading about the actual mechanism at work.

Subclinical pregnancy loss, mentioned in the caption, is a real phenomenon but it's rarely a sign of a treatable problem. Most early losses are random chromosomal errors. Recurrent loss is a different clinical picture entirely and requires workup beyond what any Instagram video can address.

Bottom line

This video is loosely accurate on the biology of sperm motility but thin on clinical specificity and conspicuously silent on the TRT-fertility connection that would be most relevant to its actual audience. The caption's statistics are defensible but decontextualized. If you're troubleshooting fertility, a reproductive urologist or endocrinologist is the appropriate next step, not a metaphor about tired runners.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Selena Jenner · Instagram creator

130.8K views on this video

Ever wonder why "perfectly timed" cycles still don't lead to a positive test? 🤰🔍 ​As a doctor, I see many couples frustrated by the clinical reality of Subclinical Pregnancy Loss. Research shows tha

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about who 2021 reference values define normal progressive sperm motility at?

WHO 2021 reference values define normal progressive sperm motility at 30% or above. Below this threshold warrants clinical workup, not just lifestyle adjustment.

What does the video say about exogenous testosterone suppresses fsh?

Exogenous testosterone suppresses FSH and LH, which can significantly reduce or eliminate sperm production. Men on TRT who want to conceive should discuss this with a reproductive specialist before assuming motility is their primary issue.

What does the video say about wilcox et al. (1988, nejm) estimated?

Wilcox et al. (1988, NEJM) estimated that a substantial proportion of fertilized eggs are lost before or shortly after implantation, but most of these losses involve chromosomally abnormal embryos and are not a sign of treatable infertility.

What does the video say about male factor, female factor,?

Male factor, female factor, and combined or unexplained etiologies each account for roughly one-third of infertility cases per ASRM. Poor sperm motility is one variable among many.

What does the video say about reduced motility (asthenozoospermia), low count (oligozoospermia),?

Reduced motility (asthenozoospermia), low count (oligozoospermia), and poor morphology (teratozoospermia) are distinct findings on semen analysis. The video treats them as interchangeable, which they are not clinically.

What does the video say about a semen analysis?

A semen analysis is the first-line diagnostic test for male factor infertility. It should be interpreted alongside hormonal panels including FSH, LH, and total testosterone, especially in men with any history of exogenous hormone use.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Selena Jenner, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.